Treatment of metastatic stage prostate cancer with degarelix

Details for Australian Patent Application No. 2009213751 (hide)

Owner Ferring International Center SA

Inventors Persson, Bo-Eric

Agent Davies Collison Cave

Pub. Number AU-A-2009213751

PCT Pub. Number WO2009/101533

Priority 61/147,956 28.01.09 US; 08250703.9 29.02.08 EP; 61/027,741 11.02.08 US

Filing date 10 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 38/09 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/101533 Priority application(s): WO2009/101533

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213760-Compound absorbent article with improved body contact

2009213748-Method of treating prostate cancer with the GnRH antagonist degarelix